Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 119.48
-3.79 (-3.07%)
Jul 17, 2026, 4:10 PM AEST
Cochlear Market Cap
Cochlear has a market cap or net worth of 7.81 billion as of July 17, 2026. Its market cap has decreased by -60.19% in one year.
Market Cap
7.81B
Enterprise Value
7.87B
Revenue
2.34B
Ranking
n/a
PE Ratio
22.68
Stock Price
119.48
ChartMarket Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 7.81B, an increase of 17,586.75%. That is a compound annual growth rate of 18.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 7.81B | -54.16% |
| Dec 31, 2025 | 17.05B | -10.12% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 1.92B |
| PolyNovo | 677.03M |
| Imricor Medical Systems | 577.96M |
| EBR Systems | 267.38M |
| Aroa Biosurgery | 202.35M |
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 129.79M |
| SomnoMed | 100.78M |